Literature DB >> 25878341

Coproduction of KPC-2 and IMP-10 in Carbapenem-Resistant Serratia marcescens Isolates from an Outbreak in a Brazilian Teaching Hospital.

Kesia Esther Silva1, Rodrigo Cayô2, Cecilia Godoy Carvalhaes2, Flávia Patussi Correia Sacchi3, Fernanda Rodrigues-Costa2, Ana Carolina Ramos da Silva2, Julio Croda4, Ana Cristina Gales2, Simone Simionatto5.   

Abstract

We describe an outbreak caused by KPC-2- and IMP-10-producing Serratia marcescens isolates in a Brazilian teaching hospital. Tigecycline was the only active antimicrobial agent tested. The blaIMP-10 gene was located in a new class 1 integron, named In990, carried by a nonconjugative plasmid, in contrast to blaKPC-2.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25878341      PMCID： PMC4473237          DOI： 10.1128/JCM.00727-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.

Authors:  Rodrigo E Mendes; Mariana Castanheira; Mark A Toleman; Helio S Sader; Ronald N Jones; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

2.  Serratia marcescens sepsis outbreak in a neonatal intensive care unit.

Authors:  Ugur Arslan; Ibrahim Erayman; Sevin Kirdar; Serife Yuksekkaya; Omer Cimen; Inci Tuncer; Bülent Bozdogan
Journal:  Pediatr Int       Date:  2009-08-02       Impact factor: 1.524

3.  Outbreak of bloodstream infections because of Serratia marcescens in a pediatric department.

Authors:  Elias Iosifidis; Evangelia Farmaki; Natalia Nedelkopoulou; Maria Tsivitanidou; Maria Kaperoni; Vassiliki Pentsoglou; Spyros Pournaras; Miranta Athanasiou-Metaxa; Emmanuel Roilides
Journal:  Am J Infect Control       Date:  2012-02       Impact factor: 2.918

Review 4.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

5.  Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program.

Authors:  Rodrigo E Mendes; Mark A Toleman; Julival Ribeiro; Helio S Sader; Ronald N Jones; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  Outbreak of Serratia marcescens colonization and infection traced to a healthcare worker with long-term carriage on the hands.

Authors:  Jutte J C de Vries; Willy H Baas; Kees van der Ploeg; Albert Heesink; John E Degener; Jan P Arends
Journal:  Infect Control Hosp Epidemiol       Date:  2006-10-23       Impact factor: 3.254

7.  Molecular epidemiology of Serratia marcescens outbreaks in two neonatal intensive care units.

Authors:  Vladana Milisavljevic; Fann Wu; Elaine Larson; David Rubenstein; Barbara Ross; Lewis M Drusin; Phyllis Della-Latta; Lisa Saiman
Journal:  Infect Control Hosp Epidemiol       Date:  2004-09       Impact factor: 3.254

8.  Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli.

Authors:  T Kieser
Journal:  Plasmid       Date:  1984-07       Impact factor: 3.466

9.  Identification of plasmid- and integron-borne blaIMP-1 and blaIMP-10 in clinical isolates of Serratia marcescens.

Authors:  Zhuting Hu; Wei-Hua Zhao
Journal:  J Med Microbiol       Date:  2009-02       Impact factor: 2.472

10.  Detection of SPM-1-producing Pseudomonas aeruginosa and class D β-lactamase-producing Acinetobacter baumannii isolates by use of liquid chromatography-mass spectrometry and matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Cecilia G Carvalhaes; Rodrigo Cayô; Diego M Assis; Evelin R Martins; Luiz Juliano; Maria A Juliano; Ana C Gales
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948
View more
  13 in total

Review 1.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

2.  Crystal Structures of KPC-2 and SHV-1 β-Lactamases in Complex with the Boronic Acid Transition State Analog S02030.

Authors:  Nhu Q Nguyen; Nikhil P Krishnan; Laura J Rojas; Fabio Prati; Emilia Caselli; Chiara Romagnoli; Robert A Bonomo; Focco van den Akker
Journal:  Antimicrob Agents Chemother       Date:  2016-01-04       Impact factor: 5.191

3.  Dissemination of Multidrug-Resistant Proteus mirabilis Clones Carrying a Novel Integron-Borne blaIMP-1 in a Tertiary Hospital.

Authors:  Ana Carolina Ramos; Rodrigo Cayô; Cecilia Godoy Carvalhaes; Thomas Jové; Greice Pereira da Silva; Fernanda Maciel Paschoin Sancho; Thomas Chagas-Neto; Eduardo Alexandrino Servolo Medeiros; Ana Cristina Gales
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

4.  Three challenging cases of infections by multidrug-resistant Serratia marcescens in patients admitted to intensive care units.

Authors:  Kesia Esther da Silva; Luana Rossato; Sérgio Jorge; Natasha Rodrigues de Oliveira; Frederico Schmitt Kremer; Vinícius Farias Campos; Luciano da Silva Pinto; Odir Antonio Dellagostin; Simone Simionatto
Journal:  Braz J Microbiol       Date:  2021-04-08       Impact factor: 2.476

5.  Detection and Characterization of Targeted Carbapenem-Resistant Health Care-Associated Threats: Findings from the Antibiotic Resistance Laboratory Network, 2017 to 2019.

Authors:  Sarah Sabour; Jennifer Y Huang; Amelia Bhatnagar; Sarah E Gilbert; Maria Karlsson; David Lonsway; Joseph D Lutgring; J Kamile Rasheed; Alison Laufer Halpin; Richard A Stanton; Stephanie Gumbis; Christopher A Elkins; Allison C Brown
Journal:  Antimicrob Agents Chemother       Date:  2021-09-27       Impact factor: 5.191

6.  Using Patient Risk Factors to Identify Whether Carbapenem-Resistant Enterobacteriaceae Infections Are Caused by Carbapenemase-Producing Organisms.

Authors:  Patricia J Simner; Katherine E Goodman; Karen C Carroll; Anthony D Harris; Jennifer H Han; Pranita D Tamma
Journal:  Open Forum Infect Dis       Date:  2018-05-17       Impact factor: 3.835

7.  First reported nosocomial outbreak of Serratia marcescens harboring bla IMP-4 and bla VIM-2 in a neonatal intensive care unit in Cairo, Egypt.

Authors:  Doaa Mohammad Ghaith; Mai Mahmoud Zafer; Dalia Kadry Ismail; Mohamed Hamed Al-Agamy; Marie Fe F Bohol; Ahmed Al-Qahtani; Mohammed N Al-Ahdal; Sherif M Elnagdy; Islam Yousif Mostafa
Journal:  Infect Drug Resist       Date:  2018-11-08       Impact factor: 4.003

8.  Carbapenemase production among less-common Enterobacterales genera: 10 US sites, 2018.

Authors:  Alicia Shugart; Garrett Mahon; Jennifer Y Huang; Maria Karlsson; Ann Valley; Megan Lasure; Annastasia Gross; Brittany Pattee; Elisabeth Vaeth; Richard Brooks; Tyler Maruca; Catherine E Dominguez; David Torpey; Drew Francis; Rachana Bhattarai; Marion A Kainer; Allison Chan; Heather Dubendris; Shermalyn R Greene; Sara J Blosser; D J Shannon; Kelly Jones; Brenda Brennan; Sopheay Hun; Marisa D'Angeli; Caitlin N Murphy; Maureen Tierney; Natashia Reese; Amelia Bhatnagar; Alex Kallen; Allison C Brown; Maroya Spalding Walters
Journal:  JAC Antimicrob Resist       Date:  2021-09-04

Review 9.  Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on β-lactams and polymyxins.

Authors:  Jorge Luiz Mello Sampaio; Ana Cristina Gales
Journal:  Braz J Microbiol       Date:  2016-10-25       Impact factor: 2.476

10.  In vitro and in vivo antibacterial activity assays of carvacrol: A candidate for development of innovative treatments against KPC-producing Klebsiella pneumoniae.

Authors:  Gleyce Hellen de Almeida de Souza; Joyce Alencar Dos Santos Radai; Marcia Soares Mattos Vaz; Kesia Esther da Silva; Thiago Leite Fraga; Leticia Spanivello Barbosa; Simone Simionatto
Journal:  PLoS One       Date:  2021-02-22       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.